In the June quarter, Mumbai-based Sun Pharmaceutical Industries posted a 43 per cent rise in net profits to Rs 2,061 crore. The consolidated net profit...
Sun Pharmaceuticals Industries has received approval from USFDA, for its psoriasis drug Ilumya. Ilumya is generically known as tildrakizumab-asmn and comes under specialty drugs –...